{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:41:54Z","timestamp":1789915314961,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5428,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.nurt.2008.08.012","type":"journal-article","created":{"date-parts":[[2008,10,4]],"date-time":"2008-10-04T15:11:21Z","timestamp":1223133081000},"page":"528-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inflammatory Demyelinating Neuropathies and Neuropathies Associated with Monoclonal Gammopathies: Treatment Update"],"prefix":"10.1016","volume":"5","author":[{"given":"Andreas J.","family":"Steck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Czaplinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2008.08.012_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barre syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nurt.2008.08.012_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11940-000-0029-7","article-title":"Guillain-Barre Syndrome","volume":"2","author":"van Der Meche","year":"2000","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barre syndrome","volume":"45","author":"Van der Meche","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","article-title":"Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features","volume":"47","author":"Visser","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.08.012_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1744-9987.1997.tb00027.x","article-title":"Plasma exchange versus intravenous immunoglobulin for Guillain-Barre syndrome","volume":"1","author":"Hughes","year":"1997","journal-title":"Ther Apher"},{"key":"10.1016\/j.nurt.2008.08.012_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1097-4598(200102)24:2<288::AID-MUS150>3.0.CO;2-H","article-title":"Mechanisms of early and late recovery in acute motor axonal neuropathy","volume":"24","author":"Kuwabara","year":"2001","journal-title":"Muscle Nerve"},{"issue":"Pt 9","key":"10.1016\/j.nurt.2008.08.012_bib9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nurt.2008.08.012_bib11","first-page":"301","article-title":"Immunopathology and treatments of Guillain-Barre syndrome and of chronic inflammatory demyelinating polyneuropathy","volume":"158","author":"Radziwill","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nurt.2008.08.012_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004150200000","article-title":"Chronic inflammatory demyelinative polyneuropathy","volume":"249","author":"Said","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib13","first-page":"115","article-title":"Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"79","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s100720070116","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients","volume":"21","author":"Sghirlanzoni","year":"2000","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nurt.2008.08.012_bib15","article-title":"Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)","author":"Uzenot","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nurt.2008.08.012_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jnnp.63.6.765","article-title":"Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy","volume":"63","author":"Meucci","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00415-005-0805-0","article-title":"Treatment of dys-immune neuropathies","volume":"252","author":"Nobile-Orazio","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.410300119","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin","volume":"30","author":"Cornblath","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1991.00530140113024","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"van Doorn","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/WCO.0b013e32830efc03","article-title":"Intravenous immunoglobulins in the treatment of immune neuropathies","volume":"21","author":"Kieseier","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib22","first-page":"493","article-title":"Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin","volume":"88","author":"Choudhary","year":"1995","journal-title":"Qjm"},{"issue":"Pt 4","key":"10.1016\/j.nurt.2008.08.012_bib23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1212\/WNL.62.1.155","article-title":"Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg","volume":"62","author":"Walk","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00415-004-0323-5","article-title":"Immune mediated neuropathies\u2013an update on therapeutic strategies","volume":"251","author":"Czaplinski","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib26","first-page":"S32","article-title":"Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy","volume":"158","author":"Hughes","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nurt.2008.08.012_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp.2007.128694","article-title":"Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP","volume":"79","author":"Axelson","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000116045","article-title":"Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia","volume":"25","author":"Roth","year":"1986","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","article-title":"Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease","volume":"11","author":"Parry","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mus.20296","article-title":"Multifocal motor neuropathy: current concepts and controversies","volume":"31","author":"Nobile-Orazio","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mus.20236","article-title":"Lewis-Sumner syndrome and multifocal motor neuropathy","volume":"31","author":"Verschueren","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.49.5.1289","article-title":"Multifocal motor neuropathy","volume":"49","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.47.4.951","article-title":"The sensitivity and specificity of anti-GM1 antibody testing","volume":"47","author":"Taylor","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib36","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"issue":"Pt 1","key":"10.1016\/j.nurt.2008.08.012_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study","volume":"124","author":"Leger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J","article-title":"Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment","volume":"48","author":"Van den Berg-Vos","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jnnp.62.4.391","article-title":"Long term follow up of multifocal motor neuropathy with conduction block under treatment","volume":"62","author":"Azulay","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.nurt.2008.08.012_bib40","article-title":"IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results","volume":"252","author":"Nobile-Orazio","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib41","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/01.WNL.0000145706.04340.25","article-title":"Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg","volume":"63","author":"Ruegg","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib42","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp.72.6.761","article-title":"Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block","volume":"72","author":"Nobile-Orazio","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.48.3.700","article-title":"Electrophysiologic findings in multifocal motor neuropathy","volume":"48","author":"Katz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003217","article-title":"Immunosuppressive treatment for multifocal motor neuropathy","author":"Umapathi","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nurt.2008.08.012_bib45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.48.2.544","article-title":"Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis","volume":"48","author":"Abbruzzese","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0404.1991.tb04900.x","article-title":"Chronic acquired demyelinating motor neuropathy","volume":"84","author":"Hausmanowa-Petrusewicz","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nurt.2008.08.012_bib47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mus.20524","article-title":"High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy","volume":"34","author":"Brannagan","year":"2006","journal-title":"Muscle Nerve"},{"issue":"Pt 8","key":"10.1016\/j.nurt.2008.08.012_bib49","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/brain\/awm144","article-title":"Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial","volume":"130","author":"Piepers","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(05)70074-0","article-title":"Multifocal motor neuropathy","volume":"4","author":"Van Asseldonk","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib51","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nurt.2008.08.012_bib52","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2008.08.012_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.08.012_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1529-8027.2007.00129.x","article-title":"Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M","volume":"12","author":"Benedetti","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nurt.2008.08.012_bib55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/mus.20386","article-title":"Worsening after rituximab treatment in anti-mag neuropathy","volume":"32","author":"Broglio","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib56","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1200\/JCO.2005.04.6474","article-title":"Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia","volume":"24","author":"Noronha","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nurt.2008.08.012_bib57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mus.10359","article-title":"Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies","volume":"27","author":"Renaud","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.wco.0000245368.36576.0d","article-title":"Anti-myelin-associated glycoprotein neuropathy","volume":"19","author":"Steck","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.66.5.575","article-title":"Successful treatment of IgM paraproteinaemic neuropathy with fludarabine","volume":"66","author":"Wilson","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2008.08.012_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<528::AID-MUS15>3.0.CO;2-L","article-title":"IgM M-protein with antibody activity against gangliosides with disialosyl residue in sensory neuropathy binds to sensory neurons","volume":"19","author":"Oka","year":"1996","journal-title":"Muscle Nerve"},{"issue":"Pt 10","key":"10.1016\/j.nurt.2008.08.012_bib61","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib62","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mus.20835","article-title":"Clinical and immunological spectrum of the Miller Fisher syndrome","volume":"36","author":"Lo","year":"2007","journal-title":"Muscle Nerve"},{"issue":"Pt 11","key":"10.1016\/j.nurt.2008.08.012_bib63","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mus.880160710","article-title":"Localization of GM1 and GD1b antigens in the human peripheral nervous system","volume":"16","author":"Kusunoki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410390404","article-title":"Experimental sensory neuropathy induced by sensitization with ganglioside GD1b","volume":"39","author":"Kusunoki","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2008.08.012_bib66","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJM199212313272705","article-title":"Plasma-cell dyscrasia with polyneuropathy","volume":"327","author":"Miralles","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2008.08.012_bib67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","article-title":"POEMS Syndrome","author":"Dispenzieri","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.nurt.2008.08.012_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.10182","article-title":"Patterns of nerve conduction abnormalities in POEMS syndrome","volume":"26","author":"Sung","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1529-8027.2003.03019.x","article-title":"Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases","volume":"8","author":"Vital","year":"2003","journal-title":"J Peripher Nerv Syst"},{"issue":"4 Pt 1","key":"10.1016\/j.nurt.2008.08.012_bib70","first-page":"393","article-title":"[POEMS syndrome: imaging of skeletal manifestations, a study of 8 cases]","volume":"84","author":"Michel","year":"2003","journal-title":"J Radiol"},{"key":"10.1016\/j.nurt.2008.08.012_bib71","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.nurt.2008.08.012_bib72","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"issue":"Pt 8","key":"10.1016\/j.nurt.2008.08.012_bib73","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2008.08.012_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hon.845","article-title":"Review of peripheral neuropathy in plasma cell disorders","volume":"26","author":"Silberman","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.nurt.2008.08.012_bib75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/(SICI)1097-4598(199708)20:8<1035::AID-MUS16>3.0.CO;2-U","article-title":"Marked improvement of severe polyneuropathy associated with multifocal osteosclerotic myeloma following surgery, radiation, and chemotherapy","volume":"20","author":"Rotta","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2008.08.012_bib76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1703670","article-title":"Peripheral blood stem cell transplantation for POEMS syndrome","volume":"30","author":"Peggs","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.nurt.2008.08.012_bib77","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/annonc\/mdm602","article-title":"Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome","volume":"19","author":"Dietrich","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nurt.2008.08.012_bib78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1529-8027.2002.02007.x","article-title":"Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients","volume":"7","author":"Gemignani","year":"2002","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nurt.2008.08.012_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nurt.2008.08.012_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","article-title":"Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab","volume":"28","author":"Braun","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.nurt.2008.08.012_bib81","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0889-8588(05)70129-5","article-title":"Cryoglobulinemia","volume":"13","author":"Dispenzieri","year":"1999","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300466X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300466X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2008.08.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:39:44Z","timestamp":1761806384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792300466X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S187874792300466X"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.012","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory Demyelinating Neuropathies and Neuropathies Associated with Monoclonal Gammopathies: Treatment Update","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2008.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}